Medline Inc. (MDLN) has a MoatMap StockRank of 28/100 based on Quality (52/100), Value (35/100), and Momentum (27/100) factor scores. The current signal is SELL. Medline is a healthcare distributor with low operating margins and high capital requirements. It lacks the pricing power, proprietary IP, and structural tailwinds of our high-conviction healthcare themes.
Medline Inc. is a global manufacturer and distributor of medical supplies and solutions, serving the entire continuum of care from hospitals and clinics to nursing homes. The company's competitive advantage lies in its extensive product portfolio and vertically integrated supply chain, making it a crucial infrastructure provider to the healthcare industry.
| Price | $36.01 |
| Market Cap | $31.1B |
| P/E (TTM) | 30.22 |
| P/E (Forward) | 20.64 |
| Price/Book | 2.59 |
| Return on Equity | 6.1% |
| Return on Invested Capital | 5.7% |
| Debt/Equity | 65.31 |
| Gross Margin | 25.9% |
| Operating Margin | 5.4% |
| Revenue Growth | 10.7% |
Medline Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).